DE69506086D1 - Zusammensetzung mit gesteuerter freisetzung - Google Patents

Zusammensetzung mit gesteuerter freisetzung

Info

Publication number
DE69506086D1
DE69506086D1 DE69506086T DE69506086T DE69506086D1 DE 69506086 D1 DE69506086 D1 DE 69506086D1 DE 69506086 T DE69506086 T DE 69506086T DE 69506086 T DE69506086 T DE 69506086T DE 69506086 D1 DE69506086 D1 DE 69506086D1
Authority
DE
Germany
Prior art keywords
composition
controlled release
release
controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69506086T
Other languages
English (en)
Other versions
DE69506086T2 (de
Inventor
Daniel Bar-Shalom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BM RES AS
Original Assignee
BM RES AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BM RES AS filed Critical BM RES AS
Application granted granted Critical
Publication of DE69506086D1 publication Critical patent/DE69506086D1/de
Publication of DE69506086T2 publication Critical patent/DE69506086T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
DE69506086T 1994-02-23 1995-02-23 Zusammensetzung mit gesteuerter freisetzung Expired - Lifetime DE69506086T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK22294 1994-02-23
PCT/DK1995/000080 WO1995022962A1 (en) 1994-02-23 1995-02-23 Controlled release composition

Publications (2)

Publication Number Publication Date
DE69506086D1 true DE69506086D1 (de) 1998-12-24
DE69506086T2 DE69506086T2 (de) 1999-05-20

Family

ID=8091111

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69506086T Expired - Lifetime DE69506086T2 (de) 1994-02-23 1995-02-23 Zusammensetzung mit gesteuerter freisetzung

Country Status (7)

Country Link
US (3) US6787156B1 (de)
EP (1) EP0746310B1 (de)
JP (2) JP4194114B2 (de)
AU (1) AU1806895A (de)
DE (1) DE69506086T2 (de)
DK (1) DK0746310T3 (de)
WO (1) WO1995022962A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP970485A2 (en) * 1996-09-13 1998-08-31 Joerg Rosenberg Process for producing solid pharmaceutical forms
US8524277B2 (en) 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
CA2327685C (en) * 1998-04-03 2008-11-18 Bm Research A/S Controlled release composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
WO2002005788A1 (en) * 2000-07-14 2002-01-24 Universiteit Gent Composite solid shaped articles for the controlled delivery of biologically active ingredients
JP2004531467A (ja) 2000-11-28 2004-10-14 エフ　エム　シー　コーポレーション 可食性ｐｇａ被覆組成物
CA2363902C (en) * 2000-12-07 2005-07-26 Warner-Lambert Company Process and system for controlled-release drug delivery
ITMI20011632A1 (it) * 2001-07-27 2003-01-27 Sanofi Synthelabo Composizione solida contenente spore di batteri non patogeni del genere bacillus
JP2005502426A (ja) 2001-09-14 2005-01-27 フランシス ジェイ マーティン 治療剤の徐放のための微細加工ナノ細孔デバイス
US20050019399A1 (en) 2001-09-21 2005-01-27 Gina Fischer Controlled release solid dispersions
EP2957281A1 (de) 2001-09-21 2015-12-23 Egalet Ltd. Polymer-freigabe-system
WO2003024430A1 (en) * 2001-09-21 2003-03-27 Egalet A/S Morphine polymer release system
US6592901B2 (en) * 2001-10-15 2003-07-15 Hercules Incorporated Highly compressible ethylcellulose for tableting
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) * 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
US20040151772A1 (en) * 2002-11-08 2004-08-05 Egalet A/S Controlled release carvedilol compositions
DE602004031096D1 (de) * 2003-03-26 2011-03-03 Egalet As Morphin-system mit kontrollierter freisetzung
DE602004025159D1 (de) * 2003-03-26 2010-03-04 Egalet As Matrixzubereitungen für die kontrollierte Darreichung von Arzneistoffen
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8864730B2 (en) 2005-04-12 2014-10-21 Rochester Medical Corporation Silicone rubber male external catheter with absorbent and adhesive
JP5161075B2 (ja) * 2005-06-03 2013-03-13 エガレット エイ／エス 分散媒体の第１フラクションとマトリックスの第２フラクションを有し、第２フラクションが胃腸の液体に少なくとも部分的に最初に曝される固形の医薬組成物
EP1942872A2 (de) * 2005-11-04 2008-07-16 Eastman Chemical Company Carboxyalkylcelluloseester zur verabreichung von schwer löslichen pharmazeutischen wirkstoffen
EP2104493A2 (de) * 2007-01-16 2009-09-30 Egalet A/S Verwendung i) eines polyglycols und n) einer wirkstoffsubstanz zur herstellung einer pharmazeutischen zusammensetzung i) zur abschwächung des risikos alkoholbedingten dose-dumpings und/oder ii) zur reduzierung des risikos eines medikamentenmissbrauchs
CA2687192C (en) 2007-06-04 2015-11-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
EP2393484A1 (de) 2009-02-06 2011-12-14 Egalet Ltd. Gegen missbrauch durch alkoholeinnahme widerstandsfähige zusammensetzung mit unmittelbarer freisetzung
AU2010211376B2 (en) 2009-02-06 2013-08-22 Egalet Ltd. Pharmaceutical compositions resistant to abuse
AU2010265213B2 (en) 2009-06-24 2012-08-23 Egalet Ltd. Controlled release formulations
WO2010151682A2 (en) * 2009-06-25 2010-12-29 Rochester Medical Corporation Silicone catheter containing chlorhexidine gluconate
BR112012013676A2 (pt) * 2009-12-07 2016-04-19 Mcneil Ppc Inc revestimento por imersão parcial de formas de dosagem para liberação modificada
SG174658A1 (en) 2010-04-01 2011-10-28 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
US9200164B2 (en) * 2010-04-26 2015-12-01 Dsm Ip Assets B.V. Coating system
US9707375B2 (en) 2011-03-14 2017-07-18 Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. Catheter grip and method
BR112014004753A2 (pt) 2011-08-30 2017-03-28 Univ Gent formulação de liberação de multicamadas
BR112015000150A2 (pt) 2012-07-06 2017-06-27 Egalet Ltd composições farmacêuticas dissuasoras de abuso de liberação controlada
US9872969B2 (en) 2012-11-20 2018-01-23 Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. Catheter in bag without additional packaging
US10092728B2 (en) 2012-11-20 2018-10-09 Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. Sheath for securing urinary catheter
US10821209B2 (en) 2013-11-08 2020-11-03 Hollister Incorporated Oleophilic lubricated catheters
US9339580B2 (en) 2013-11-27 2016-05-17 Kimberly-Clark Worldwide, Inc. Flushable tampon applicator
US9320656B2 (en) 2013-11-27 2016-04-26 Kimberly-Clark Worldwide, Inc. Water-dispersible thermoplastic injection molded composition
US9456931B2 (en) 2013-11-27 2016-10-04 Kimberly-Clark Worldwide, Inc. Thermoplastic and water-dispersible injection moldable materials and articles
MX2017002457A (es) 2014-08-26 2017-05-19 Bard Inc C R Cateter urinario.
BR112018014661A2 (pt) 2016-01-20 2018-12-11 Theravida Inc composição e composição para uso
EP4046609A1 (de) * 2016-09-30 2022-08-24 Mati Therapeutics Inc. Augenmedikation mit verzögerter freisetzung und verwendung davon
CA3070865A1 (en) 2017-09-19 2019-03-28 C.R. Bard, Inc. Urinary catheter bridging device, systems and methods thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1430684A (en) 1972-06-26 1976-03-31 Lowey H Prolonged release lozenges
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
WO1989009066A1 (en) 1988-03-24 1989-10-05 Bukh Meditec A/S Controlled release composition
US5082669A (en) * 1989-07-20 1992-01-21 Dainippon Pharmaceutical Co., Ltd. Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
DK469989D0 (da) 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
US5126146A (en) * 1989-10-23 1992-06-30 Merck & Co., Inc. Cellulosic coating
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive

Also Published As

Publication number Publication date
DE69506086T2 (de) 1999-05-20
US6787156B1 (en) 2004-09-07
JP2006052228A (ja) 2006-02-23
EP0746310B1 (de) 1998-11-18
JPH09509184A (ja) 1997-09-16
WO1995022962A1 (en) 1995-08-31
AU1806895A (en) 1995-09-11
DK0746310T3 (da) 1999-08-02
JP4194114B2 (ja) 2008-12-10
US20050019405A1 (en) 2005-01-27
EP0746310A1 (de) 1996-12-11
US20080254124A1 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
DE69506086T2 (de) Zusammensetzung mit gesteuerter freisetzung
DK1527775T3 (da) Tramadolholdig sammensætning med kontrolleret frigivelse
ATE252386T1 (de) Galantamin-zusammensetzung mit gesteuerter freisetzung
DE69526966D1 (de) Hautkräftigende kometische zusammensetzung
DE69826289D1 (de) Mikroverkapselte ngf zusammensetzungen mit geregelter freigabe
DE69627716D1 (de) Perfluorelastomer-zusammensetzung mit erhöhter vulkanisationseigenschaften
DE69810608T2 (de) Eingekapseltes material mit kontrollierter freisetzung
DE69718508T2 (de) Antitraspirant zusammensetzung
BR9508318A (pt) Composição impadora concentrada
ID18359A (id) Komposisi mikrokapsul
FI954773A0 (fi) Antihypertriglyserideeminen koostumus
AT4589U3 (de) Oxycodon-zusammensetzung mit kontrollierter freisetzung
DE69405353D1 (de) Vernetzbare Organopolysiloxanzusammensetzung
ID19589A (id) Komposisi
BR9305261A (pt) Composição implantável com liberação controlada
ITMI940362A0 (it) Composizione antitosse
DE69532410D1 (de) Härtbare zusammensetzung
BR9707835A (pt) Composiç
BR9509899A (pt) Composição modificadora de sabor
BR9709815A (pt) Composicão
KR950703340A (ko) 항엠알에스에이 조성물
DE69504847D1 (de) Düngemittel mit gesteuerter freigabe
NO991735D0 (no) Vaskemiddelblanding
DE9408070U1 (de) Lösespitze
ID17791A (id) Komposisi nonafluorometoksibutana

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 746310

Country of ref document: EP

Representative=s name: ZACCO DR. PETERS UND PARTNER, DE